We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

March 21, 2005

USA, ex rel., vs. Fresenius Medical

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 3, 2012

    DaVita Inks $55 Million Settlement In Epogen FCA Suit

    Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for free supplies of Amgen Inc.’s anemia drug Epogen.

1 other articles on this case. View all »

Parties

To view the parties, register now.